Skip to main content
Omar Aljitawi, MD, Oncology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

OmarSalahAljitawiMD

Oncology Rochester, NY

Hematologic Oncology

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Dr. Aljitawi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Aljitawi's full profile

Already have an account?

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
  • East Tennessee State University/Quillen College of Medicine
    East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 2001 - 2004
  • University of Jordan Faculty of Medicine
    University of Jordan Faculty of MedicineClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2026
  • CA State Medical License
    CA State Medical License 2007 - 2025
  • KS State Medical License
    KS State Medical License 2004 - 2016

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
    Omar S. Aljitawi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer Therapy
    Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer TherapyJanuary 4th, 2017

Hospital Affiliations